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Abstract. Most research to identify endocrine-disrupting chemicals and their impacts has re-
lied on mammalian models or in vitro systems derived from them. But nuclear receptors
(NRs), the proteins that transduce hydrophobic hormonal signals and are major mediators of
endocrine disruption, emerged early in animal evolution and now play biologically essential
roles throughout the Metazoa. Nonmammalian vertebrates and invertebrates, many of which
are of considerable ecological, economic, and cultural importance, are therefore potentially
subject to endocrine disruption by synthetic environmental pollutants.
Are methods that rely solely on mammalian models adequate to predict or detect all
chemicals that may disrupt NR signaling? Regulation of NRs by small hydrophobic mole-
cules is ancient and evolutionarily labile. Within and across genomes, the NR superfamily is
very diverse, due to many lineage-specific gene and genome duplications followed by inde-
pendent divergence. Receptors in nonmammalian species have in many cases evolved unique
molecular and organismal functions that cannot be predicted from those of their mammalian
orthologs. Endocrine disruption is therefore likely to occur throughout the metazoan king-
dom, and a significant number of the thousands of synthetic chemicals now in production
may disrupt NR signaling in one or more nonmammalian taxa. Many of these endocrine dis-
ruptors will not be detected by current regulatory/scientific protocols, which should be re-
formulated to take account of the diversity and complexity of the NR gene family.
ENDOCRINE DISRUPTION AND NUCLEAR RECEPTOR EVOLUTION
Nuclear receptors (NRs) are evolutionarily related multidomain proteins that bind to specific DNA mo-
tifs and up- or down-regulate transcription of specific genes. Most NRs bind tightly to hydrophobic hor-
mones and other ligands, which effect a conformational change in the receptor, causing it to switch into
transcriptionally active or repressive modes [2]. Many plant and synthetic chemicals, including pesti-
cides, plastics components, and industrial by-products, have been found to bind to and thereby mimic,
block, or otherwise disrupt the natural activity of vertebrate NRs [2,3].
The premise of this paper is that current biological systems carry the traces of the evolutionary
history by which they were created. A historical perspective on the nuclear receptor superfamily allows
us to organize and interpret the diversity of NRs and their properties in a biologically meaningful way,
to discover patterns in the functional and evolutionary dynamics of NRs, and to predict the distribution
of receptors in taxa that have not been well studied. Evolutionary analysis can, therefore, yield useful
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In this paper, I review knowledge of nuclear receptor evolution and survey the NR complement of major
nonmammalian taxa, with a focus on implications for efforts to identify and manage endocrine-dis-
rupting synthetic chemicals.
ANCIENT AND CONTINUING RECEPTOR DIVERSIFICATION
The NR superfamily, like other gene families, is the product of an ongoing process of genomic diversi-
fication within and among species. There are over 1000 nuclear receptor sequences in the SMART data-
base  of  protein  family  domains  [4].  The  genomes  of  humans,  Drosophila  melanogaster and
Caenorhabditis elegans contain 49, 21, and ~270 NRs, respectively [5]. NRs have a conserved domain
structure and identifiable sequence homology to each other in their DNA-binding domains (DBDs) and
ligand-binding domains (LBDs). BLAST searches indicate no statistically significant similarity to any
other gene family. This pattern indicates that all NRs evolved by descent from a single ancestral NR—
the origin of which remains unknown—through a series of gene duplications. 
Because gene sequences diverge independently after duplication, the evolutionary relationships
among NRs form a tree-like nested hierarchy, and the techniques of phylogenetic systematics can be
used to reconstruct the history of NR diversification. As shown in Fig. 1, analysis of a large set of nu-
clear receptor sequences indicates that there are five evolutionary classes of nuclear receptors: (1) the
vitamin D receptor (VDR), ecdysone receptor (EcR), retinoic acid receptors (RARs), thyroid hormone
receptors (ThRs), and a number of receptors involved in cholesterol and xenobiotic metabolism; (2) the
peroxisome proliferators activated receptors (PPARs) and several related orphans, which are involved
in cell differentiation, development, and metabolism; (3) NGFI-B and related “orphan” receptors (re-
ceptors with no known ligand), which function in development and immunity; (4) the reproductive re-
ceptors, including steroidogenic factor 1 (SF-1), the gonadal and adrenal steroid and related receptors
of vertebrates, and germ-cell nuclear factor (GCNF); and (5) the retinoid x receptors (RXRs) and re-
lated orphans, most of which are involved in development. Most of the groups are well supported, al-
though certain relationships (such as placement of the RARs and ThRs) are sensitive to alignment and
analysis parameters. This classification, like an earlier parsimony analysis [6], is different from the re-
sults of an earlier NR phylogeny/classification, which used a smaller number of sequences and the less
reliable neighbor-joining method of phylogenetic inference [7]. The most important differences are the
existence of distinct classes 1 and 2 and the close relationship of the gonadal/adrenal steroid receptors
to SF-1 and GCNF.
NR diversity is ancient and therefore widespread. Five groups of receptors, all in the RXR and
SF-1 classes, have been identified in both diploblastic Cnidaria (jellyfish, corals, and anemones) and
triploblastic animals (Fig. 1). This finding indicates that the NR superfamily had already achieved con-
siderable diversity before the advent of the bilaterally symmetric metazoa. By the time the lineages of
protostomes  (arthropods,  nematodes,  mollusks,  annelids,  etc.),  and  deuterostomes  (chordates  and
echinoderms) split from each other at least 670 million years ago [8], the fundamental diversity of the
nuclear receptor superfamily had been established: 15 groups of receptors, representing all five classes,
are found in the genomes of both D. melanogaster and Homo sapiens. Only DAX-1, SHP, ThRs, and
RARs of vertebrates have no known protostome orthologs; based on current evidence, these are “re-
cent” chordate-specific novelties. These findings indicate that most NRs are ancient and distributed
throughout the Eumetazoa, making the vast majority of animal species potential targets for endocrine
disruption. 
There have also been many lineage-specific gene duplication events that created new receptors in
certain taxa. For example, there was considerable additional diversification in the vertebrate lineage, in-
dicated by the presence of two to four retained duplicates in vertebrates for each arthropod receptor
(Fig. 1). This pattern is consistent with the serial genome duplication hypothesis, which states that the
vertebrate genome is the result of two serial rounds of genome duplication [9]. Duplications that gen-
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arthropods, as detailed later in this paper. 
THE ANCESTRAL NUCLEAR RECEPTOR: ORIGIN AND FUNCTION
When did the first nuclear receptor appear, and what was its function? No nuclear receptors have been
found in any non-metazoan species, including the completely sequenced genomes of eubacteria, ar-
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Fig. 1 Phylogeny of the nuclear receptors. A reduced consensus is shown of the 12 most parsimonious trees from
analysis of 163 NR sequences of H. sapiens, D. melanogaster, Bombyx morii, Gallus gallus, Brachydanio rerio,
Xenopus laevis, and Acropora millepora. Roman type indicates vertebrate sequences; insect NRs in underlined
italic. Asterisks indicate the branch to which Cnidarian sequences connect. Numbers in parenthesis show the
number of human paralogs in each group. Ligands, when known, are to the right of the tree; synthetic ligands are
in  italics,  and  question  marks  indicate  unconfirmed  results.  On  this  phylogeny,  an  ancestral  ligand-activated
receptor is the most parsimonious reconstruction, as shown by four dark boxes (–) that indicate loss of ligand
binding if the ancestral receptor was ligand-dependent, and five light boxes (+) that indicate gain of ligand binding
if  the  ancestral  receptor  was  ligand-independent.  Node  labels  show  unweighted  branch  support  values
[53]/bootstrap values >50 %. Sequences were downloaded from the EBI SMART database [4]; the DBDs and
LBDs were extracted and then aligned using ClustalX 1.7 [54]. Parsimony analysis was conducted using PAUP*
[55] with a stepmatrix that downweights conservative substitutions and a heuristic search strategy of 100 random
taxon additions followed by TBR branch swapping. Reconstruction of change in ligand-binding status assumes
parallelism is more likely than reversal; different assumptions would change the placement but not the number of
changes.chaea, yeast, and plants. Because NRs have been identified in the three major divisions of eumeta-
zoans—cnidarians, protostomes, and deuterostomes—we can conclude that the first NRs emerged
some time after the divergence of metazoans from fungi but before the Cnidarian-Bilateria divergence
(Fig. 2). 
It has been argued that the ancestral NR was a ligand-independent receptor and that ligand bind-
ing was acquired later during NR evolution [10]. This scenario is possible, but there is no evidence to
favor it over the alternative explanation of an ancestral ligand-activated receptor. Both ligand-binding
and ligand-independent receptors have been identified in protostomes, deuterostomes, and cnidarians
[11]; the inferred age of ligand-binding is therefore the same as the inferred age of ligand-independent
receptors. Mechanistically, either scenario is plausible, although neither a complete loss of ligand acti-
vation nor a gain of ligand binding from a more ancient orphan has been unambiguously established in
the evolution of NRs. 
The most reliable means for inferring the characteristics of ancient proteins is by reconstructing
ancestral functional states using phylogenetic methods. Based on the parsimony criterion, the best-sup-
ported hypothesis of ancestral function is the one that requires the fewest parallel gains or reversals on
a gene family tree. As Fig. 1 shows, the NR phylogeny weakly supports an ancestral ligand-binding re-
ceptor if the tree is rooted between groups 4 and 5; the same would be true if it were rooted with an an-
cient ligand-binding NR like RXR in a basal position. If the tree were rooted on an ancient orphan re-
ceptor like COUP, an ancestral orphan receptor would be weakly favored. There is presently no way to
determine which of these receptors should be used as the root, so current evidence does not support ei-
ther scenario over the other.
Whatever the ligand-binding characteristics of the first NR were, there is no doubt that ligand
binding is very ancient. Ligand binding must have evolved very early in the radiation of the animal
phyla from an ancient eumetazoan ancestor, as shown by the presence of conserved ligand binding in
Cnidaria and Bilateria. It also must have very early in the diversification of the NR superfamily into its
five classes, as Fig. 1 shows. Virtually all receptors inherit the capacity to be ligand-activated and there-
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Fig. 2 Taxonomic distribution of nuclear receptors. A reduced phylogeny of living kingdoms and selected metazoan
taxa is shown, with the number of NR paralogs that have been sequenced from each group. Number of NRs in
jawed  vertebrates,  arthropods,  and  nematodes  are  derived  from  the  complete  genomes  of  H.  sapiens,  D.
melanogaster, and C. elegans, respectively. Absence of NRs in plants, fungi, and prokaryotes is also supported by
whole genome sequences. Other NR numbers in metazoa are inferred from screening efforts and are likely to
underestimate  the  total  NR  complement  of  each  group.  M,  Metazoa;  B,  Bilateria;  P,  Protostomia;  D,
Deuterostomia; E, Ecdysozoa; L, Lophotrochozoa, within the last century. These substances serve as NR ligands
because their stereochemistry allows them to fit by chance into NR binding pockets, which have not been selected
over the long term to exclude binding of these substances.fore are potential targets for endocrine disruption. Further, the ancient nature of ligand binding makes
it likely that endogenous ligands and endocrine disruptors will be discovered for many orphan recep-
tors, as has already occurred for many [12,13]. 
PLASTICITY IN THE EVOLUTION OF LIGAND BINDING 
Since the first ligand-binding receptor, there has been remarkable diversification of receptors’ ligand-
specifity. All NR ligands are hydrophobic and of relatively small size, but beyond these commonalities
they are very diverse. High-affinity endogenous ligands for NRs include a variety of cholesterol-deriv-
atives (steroid hormones, vitamin D, bile acids and other cholesterol metabolites), retinoids, modified
amino acids (thyroid hormone), prostaglandins, leukotrienes, and several kinds of fatty acids and ben-
zoates. 
Many of the gene duplications by which NRs diversified have been followed by the evolution of
novel ligand affinity. This is true even for the relatively recent chordate-specific duplications. For ex-
ample, the vertebrate gonadal/andrenal steroid receptors and the members of the VDR and LXR/FXR
groups are each activated by a unique hormone or group of hormones that do not bind to the others with
high affinity. (The estrogen receptors α and β are an exception, although they do vary in their affinity
for endocrine disruptors [14]). 
Receptors have also evolved affinity for new ligands after speciation events. The ecdysone re-
ceptor of arthropods is orthologous to the FXR, LXRα, and LXRβ of vertebrates, which bind oxysterols
and bile acids [15], but vertebrates do not respond to ecdysteroids. A similar pattern is found with more
recent divergences: the principal ligand for the teleost androgen receptor, for example, is not testos-
terone (T) or 5α-dihydro-T as it is in tetrapods, but 11-ketoT [16]. It is thus impossible to predict the
ligands or EDs that will bind to a receptor by extrapolation from other—even closely related —recep-
tors or model species from other classes or phyla. 
PARALLEL EVOLUTION OF LIGAND SPECIFICITY AND PROMISCUITY
There is a surprising lack of consistency in the evolution of certain types of ligands on the NR phylo-
geny. Steroids are bound by the adrenal/gonadal steroid receptors as well as by NRs in the distant VDR
group, but the receptors that intervene in the tree between these groups are orphans or bind nonsteroidal
ligands. Similarly, RXRs and the distantly related RARs are both activated by retinoic acids. The abil-
ity to bind steroids or retinoids must, therefore, be either an ancestral character lost and then regained
in the more recent receptor group or a parallel acquisition in the NR classes in which it is found. 
The use of steroids and similar molecules as high-affinity endocrine ligands has evolved in par-
allel in numerous other gene families. In plants, brassinosteroids bind to membrane receptor kinases and
function as critical regulators of plant development [17]. Steroids regulate reproduction in the fungus
Achyla ambisexualis [18], but fungi lack NRs. And in nitrogen-fixing symbiotic bacteria, the unrelated
protein NodD is an intracellular transcriptional regulator that is activated by flavonoids excreted by the
partner plant. NodD has a mode of action very similar to that of the NRs; NodD is antagonized by sev-
eral pesticides and industrial chemicals that also disrupt vertebrate steroid receptors [19]. All these re-
ceptors  are  potential—and  ecologically  important—targets  for  environmental  endocrine  disruptors
(EDs).
That several unrelated families of proteins independently evolved the ability to act as high-affin-
ity receptors for steroids and chemically similar compounds suggests that these substances have intrin-
sic properties that pre-adapt them to long-distance signaling functions. Steroids are small and lipid sol-
uble, which allows them to cross cell membranes. Their chair-like polycyclic structure makes them rigid
enough to establish stereospecific binding relationships with receptors, and their structural complexity
allows for the synthesis of hundreds of unique compounds by substitution of small moieties at various
points around the steroid nucleus. Finally, steroids are metabolically cheap to make, since cholesterol
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in eukaryotes. 
NRs, in turn, have evolved their affinity for one or a few specific ligands in the context of the en-
dogenous and exogenous chemical background of the organisms of which they are a part. Virtually all
NRs are potentially promiscuous, as shown by the phenomenon of endocrine disruption and the exis-
tence of synthetic pharmaceuticals that bind receptors with very high affinity. This pattern of endoge-
nous specificity and xenobiotic promiscuity is likely to have an evolutionary explanation. The function
of most receptors is to transduce an endocrine signal, which indicates the internal state or environmen-
tal context of the organism, into a specific cellular response. (There are several broad-specificity re-
ceptors, but these regulate metabolism of the ligands that bind to them rather than more fundamental
developmental or physiological responses). Receptors that are activated or antagonized by other com-
pounds present in the organisms’ endogenous chemistry or diet would add noise into the information
processing capacity of the cell and organism, impairing its ability to regulate its development or respond
to environmental conditions. Natural selection is, therefore, expected to drive receptors towards greater
specificity for their primary ligands. In contrast, xenobiotic drugs and industrial chemicals have been
created within the last century. These substances serve as NR ligands because their stereochemistry al-
lows them to fit by chance into NR binding pockets, which have not been selected over the long term
to exclude binding of these substances. 
This promiscuity for evolutionarily novel ligands predicts that a nontrivial portion of recently de-
veloped hydrophobic synthetic chemicals of small to moderate size will bind to and disrupt nuclear re-
ceptors. There are an estimated 87000 synthetic substances in commerce, plus thousands more formed
and released as by-products of chemical production, use, and combustion [20]. Many of these—in-
cluding polymers and hydrophilic molecules—are unlikely to be NR ligands. But a substantial number
have shapes that may attract them to the hydrophobic cores of NRs. The affinity of novel ligands for re-
ceptors is often low, but pharmacokinetic differences and simultaneous exposure to many EDs may
make environmental exposures significant [21]. 
DIVERSIFICATION OF ORGANISMAL FUNCTIONS
The regulatory roles played by NRs at the organismal level also reveals considerable evolutionary plas-
ticity. The EcR of arthropods, the master regulator of insect metamorphosis, is orthologous to a group
of three hepatic receptors (FXR, LXRα, and LXRβ), which regulate cholesterol homeostasis in verte-
brates. It is not closely related to the thyroid hormone receptor, which regulates metamorphosis in am-
phibians. Similarly, the SEX-1 receptor of nematodes is involved in sex determination, but its ortholog
E78a functions in insect metamorphosis [22]. 
It is, therefore, not possible to predict from distantly related mammalian models the phenotypic
consequences that will ensue when a receptor is activated or disrupted by endocrine-disrupting chemi-
cals. This makes the design of in vivo assays for environmental disruption of nuclear receptors difficult
in taxa for which we do not yet know the natural functions of nuclear receptors.
BRIEF SURVEY OF NUCLEAR RECEPTOR DIVERSITY
In the following sections, I review the distribution of NRs in major nonmammalian taxa (Fig. 2). (Birds,
reptiles, and teleosts are treated only briefly, because they are discussed in detail by Crews and col-
leagues in this volume.) For each group, I describe the identified NRs, based on taxonomically re-
stricted protein BLAST searches of the National Center for Biological Information’s nonredundant
(NR) sequence database [23]. With the exception of species whose genomes have been completely se-
quenced, these descriptions are almost certainly incomplete: the methods used to isolate NRs—PCR
and nucleic acid hybridization—are subject to false negatives, particularly when sequences have di-
verged greatly since an ancient common ancestor. Identified receptors therefore give a lower bound on
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phasizing evolutionary implications, and briefly discuss knowledge of and potential for endocrine dis-
ruption in each taxon. 
CNIDARIA
Cnidarian genomes have been found to contain 11 nuclear receptors, including phylogenetic orthologs
of the vertebrate receptor groups RXR, COUP, tailless (TLL), the testicular receptors TR2 and TR4, and
SF-1 [10,24]; several of the other Cnidarian genes are so divergent that they cannot be clearly assigned
to ortholog groups. Only one of the Cnidarian receptors, the RXR of the jellyfish Tripedalia cystophora,
has been functionally analyzed: like its mammalian ortholog, it activates gene express in the presence
of very low concentrations of 9-cis retinoic acid [11], although its organismal role remains unknown.
This receptor is therefore a candidate for endocrine disruption; if the others are also ligand-regulated,
they may also be ED targets. 
There may be other ligand-binding receptors in Cnidaria yet to be discovered. Vertebrate hor-
mone-type steroids have been identified in mass coral spawns in concentrations that correlate with re-
productive/developmental function [25], suggesting the possibility that these hormones are playing sig-
naling functions in Cnidaria and that receptors that transduce their signals may yet be discovered. No
studies of endocrine disruption in Cnidaria have been conducted, despite the fact that these animals play
important roles in some marine food webs.
ECDYSOZOANS: ARTHROPODS, NEMATODES, AND OTHER PHYLA
Bilaterally symmetric animals are divided phylogenetically and taxonomically into two major groups:
the protostomes (in which gut development occurs mouth first) and deuterostomes (in which the anus
develops first). The prostostomes are in turn divided into two great clades: the Ecdysozoa (organisms
that molt, including arthropods, nematodes, priapulids, and numerous others) and the Lophotrochozoa
(organisms with specific kinds of larvae or mouth structures, including annelids, mollusks, kinorhyncs,
sipunculans, and numerous other marine phyla) (Fig. 2).
The ecdysozoans include the model organisms D. melanogaster and C. elegans, the genomes of
which have been completely sequenced. The fruit fly contains 21 nuclear receptors, most of which are
involved in molting and metamorphosis, embryonic development, or behavior [26]. Several of these
genes appear to encode arthropod or dipteran-specific receptors—including three developmental NRs
that have no ligand-binding domains (Knirps, Kruppel, and Egon), as well as duplicates of the SF-1
gene and of the photoreceptor nuclear receptor gene (PNR). 
The nematode C. elegans presents perhaps the most radical example of lineage-specific NR di-
versity. C. elegans possesses orthologs of most of the NRs identified in arthropods, with the notable ex-
ception of EcR and RXR [27], although an RXR ortholog has been detected in the nematode Dirofilaria
immitis [28]. In addition to the previously recognized NRs, however, the C. elegans genome contains
an additional >200 nuclear receptors, and a large number are also present in Caenorhabditis briggsae
[27]. Phylogenetic analysis and gene mapping data show that the vast majority of these genes cluster
together, indicating that the excess NRs are largely due to tandem gene duplications that occurred
within the nematode lineage. Few of these receptors have been functionally assayed, but most have in-
tact ligand-binding domains with hydrophobic pockets, suggesting that they may be regulated by lig-
ands. 
No information on the nuclear receptor content of other ecdysozoan phyla are available, and lit-
tle research has been carried out on endocrine disruption in any ecdysozoans. It is likely, however, that
signaling via some ecdysozoan receptors can be disrupted by synthetic chemicals: polycyclic aromatic
hydrocarbons potentiate ecdysone signaling through the EcR, and numerous phytochemicals are EcR
antagonists [29,30]. In addition, metabolites of the insect control chemical methoprene disrupt the ac-
© 2003 IUPAC, Pure and Applied Chemistry 75, 1827–1839
Nonmammalian nuclear receptors 1833tion of juvenile hormone—another master regulator of moulting and metamorphosis, the receptor for
which has not been identified—and are also potent agonists of the mammalian RXR [31]. Insects, crus-
taceans, spiders, nematodes, and other ecdysozoans play major roles in terrestrial and marine food
webs, and some species in these groups—from butterflies to lobsters—are of considerable economic
and cultural importance. 
LOPHOTROCHOZOANS: MOLLUSKS, ANNELIDS, ETC.
The nuclear receptors of lophotrochozoans have not been well studied. Published complete or partial
sequences are available only for a COUP of an annelid and a COUP-TF, an RXR, and an NGFI-B or-
tholog from a mollusk. No studies whatsoever are available on other lophotrochozoans, such as sipun-
culans, bryozoa, or echiura. 
Recently, however, it has been discovered that one major group of receptors previously thought
to be unique to vertebrates is in fact ancient and widespread. Thornton, Need, and Crews [56] have
found that mollusk neural and reproductive tissues express a nuclear receptor gene that is unambigu-
ously orthologous to the vertebrate estrogen receptor. This finding indicates that the gonadal and adre-
nal steroid receptor family—the estrogen, androgen, progestin, and corticoid receptors—are far more
ancient than previously thought, with their origin predating the protostome-deuterostome divergence.
The ER must have been lost in the ecdysozoan lineage leading to flies and nematodes, presumably due
to evolutionary changes that made the receptor’s functions dispensable. We can therefore predict that
all lophotrochozoans and all deuterostomes—and possibly some ecdysozoans, as well—will possess es-
trogen receptor orthologs. Their endocrine systems may thus be subject to endocrine disruption by ER
agonists and antagonists. 
The discovery of an ER in mollusks provides a potential mechanism for the previously unex-
plained findings of vertebrate-type steroids, steroid-binding activity, and steroid-induced reproductive
changes in mollusks (reviewed in ref. [32]). Further, endocrine disruption and reproductive impairment
has been documented in mollusks after exposure to pollutants that are vertebrate estrogens [33]. If
steroids do play a role in mollusk reproduction via the mollusk ER, then some of the xenobiotic estro-
gens and antiestrogens now circulating in the environment have the potential to cause significant dam-
age to populations of mollusks and other ER-containing lophotrochozoan phyla, which are important in
aquatic and terrestrial ecosystems.
INVERTEBRATE DEUTEROSTOMES
Deuterostomes are composed of two major phyla: the echinoderms (sea stars and urchins) and the chor-
dates (tunicates, arrow worms, branchiostomes, and vertebrates). Very little work has been done to char-
acterize the diversity, function, or disruption of NRs in echinoderms. Only three nuclear receptors—the
orphans SF-1, COUP, and TR2/4—have been identified in echinoderms. Steroids, including testos-
terone and estradiol, however, have been found to be produced by sea stars and to vary with the ani-
mal’s reproductive cycle, suggesting a signaling role in these organisms (reviewed in ref. [31]). The
finding of an ancient origin for the estrogen receptor indicates that echinoderms are likely to possess
ER orthologs. If they regulate the response to these steroids, these receptors may be targets for en-
docrine disruption.
A bit more information is available on NRs in urochordates, the most basal chordates. A prelim-
inary study identified fragments that are apparently orthologs of RXR, SF-1, and estrogen-related re-
ceptors (ERR1) in urochordates [10]. In addition, full-length RXR and RAR sequences have been iden-
tified in the tunicate Polyandrocarpa misakiensis, and the expressed proteins, like their vertebrate
orthologs, have been shown to activate transcription in the presence of retinoic acid [34]. In addition, a
thyroid hormone receptor has been identified in the tunicate Ciona intesitnalis. Surprisingly, it did not
activate transcription in the presence of triiodothyronine (T3), the vertebrate ThR ligand, despite the
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this result is not an artifact, it suggests a possible shift during urochordate or vertebrate evolution in the
receptor’s affinity for different metabolites of thyroxine.
Tunicates are the most basal taxa in which RAR and ThR have been identified, indicating that
these receptor groups first emerged before tunicates split from the rest of the chordate lineage. Only a
single member of each group has been recovered from species in this subphylum, a pattern consistent
with the serial genome duplication hypothesis. RARs and ThRs are, therefore, expected to be present
in all chordates—including hemichordates, urochordates, and cephalochordates—and these receptors
may be targets for disruption by synthetic chemicals.
The cephalochordate genus Branchiostoma—including the species known as amphioxus—are the
invertebrates most closely related to vertebrates. Single members of the NR groups SF-1, RXR, COUP,
RAR, ERR, PPAR, FXR, and TR2/4 have been identified and sequenced in branchiostomes. Like its
vertebrate ortholog, the amphioxus RAR activates transcription in the presence of retinoic acid [36].
Each receptor appears to be present in amphioxus in a single copy—again consistent with serial genome
duplications, with both duplications occurring after the amphioxus-vertebrate divergence.
JAWLESS AND CARTILAGINOUS FISHES
Hagfish, lamprey, and elasmobranches are the most basally branching vertebrates. In hagfish, a PCR
screen found one ortholog each of COUP-TFs, PPARs, ERRs, and an unidentified steroid receptor [10];
other nuclear receptors are likely present but were not identified. 
Lamprey have been studied in more detail. One RXR, three PPARs, two ERRs, one NGFI-B and
a COUP-TF ortholog were found in a preliminary screen [10]. Subsequently, an estrogen receptor, a
progesterone-like receptor, and a corticoid receptor were identified in the sea lamprey Petromyzon mar-
inus. Phylogenetic analysis indicated that lampreys are not expected to posses orthologs of the andro-
gen, mineralocorticoid, and estrogen receptor beta, because these NRs were produced by duplications
in the jawed vertebrate lineage after its divergence from jawless fishes about 435 million years ago [37].
This picture is consistent with the vertebrate serial genome duplication hypothesis, with one duplica-
tion occurring before the divergence of lamprey from jawed vertebrates and the other occurring after.
The ancestral steroid receptor was inferred by phylogenetic methods and structure–function prediction
to have functioned as an estrogen receptor, despite the fact that estrogens are the terminal hormones in
the steroid biosynthetic pathway. The PR and AR are therefore duplicates of an ancient ER gene, which
subsequently evolved high affinity for progestins and androgens, thereby turning intermediates in the
estrogen synthesis pathway into bona fide hormones.
Very limited research has been conducted on the NRs of cartilagionous fishes. Sharks have an es-
trogen receptor, and also apparent orthologs of the androgen and glucocorticoid receptors, although the
sequences of the latter are so short that orthology to other steroid receptors cannot be ruled out. In ad-
dition, two PPARs, two Reverbs, two ERRs, and two COUPs have been identified in a preliminary
screen of shark cDNA [10]. The likely presence of orthologs to a variety of ligand-binding receptors in-
dicates that cartilaginous fishes may be targets for a wide range of endocrine disruptors. It is also clear
that some receptors in sharks have evolved lineage-specific ligand preferences. For example, the prin-
ciple mineralocorticoid is aldosterone in mammals, cortisol in telesots, but 1α-hydroxycorticosterone
in cartilaginous fishes [38].
TELEOST FISHES
Teleosts, the major group of aquatic bony fishes, appear to possess all the receptor types found in mam-
mals, although some NRs have not been specifically studied. For example, teleosts have orthologs of all
six steroid receptors found in humans and mice, and they have a full complement of RARs, RXRs,
COUPs, and thyroid hormone receptors. In fact, due to an apparent whole-genome duplication that
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tention of some duplicates and the apparent loss of others [39], bony fish have more NRs than most
mammals, birds, and reptiles do. For example, several teleost species have been found to have two an-
drogen receptors [40], two progesterone receptors [40], and three estrogen receptors [41] in contrast to
the one, one, and two members of each group, respectively, that are found in tetrapods. As sequencing
of teleost genomes continues, it is likely that most teleosts will have a set of NRs larger than tetrapods’
by a factor of up to two. 
There has been functional diversification of teleost NRs at both organismal and molecular levels.
Estrogens and estrogenic pesticides, for example, can reverse the primary sexual differentiation of male
fish, a phenomenon unknown in mammals [42]. Like the teleost androgen receptor, which has unique
ligand affinity (see above), teleost progesterone receptors are activated primarily by 17α,20β-proges-
terone and 17α,20β,21-trihydroxypregnenone, not progesterone as they are in tetrapods [43,44]. Teleost
receptors also have quantitatively different relationships with endocrine disruptors than their mam-
malian orthologs: endosulfan, dieldrin, and methoxychlor bind to the ERα of trout but not to those of
human, mouse, chicken, or lizard [45]. 
BIRDS, REPTILES, AND AMPHIBIANS
The proliferation of nuclear receptors largely stopped before the divergence of tetrapods into its major
classes, so most birds, reptiles, and amphibians have the same complement of NRs as mammals do.
There are exceptions, however: the frog Xenopus laevis, an apparent tetraploid species, has retained du-
plicates of some mammalian NRs, such as the RARs, SF-1, and ERα [46,57].
Although the number of NRs has remained more or less stable, there has been considerable func-
tional diversification of receptors in these vertebrate lineages. At the organismal level, thyroid hormone
regulates metamorphosis in amphibians, but it regulates basal metabolism, behavior, and neurological
development in nonmetamorphic vertebrates. At the molecular level, the benzoate X receptors (BXRs)
of X. laevis are activated by benzoic acids, but their mammalian ortholog PXR/SXR binds steroids with
no affinity for benzoates [47]. The potency of synthetic endocrine disruptors also varies considerably
from that in mammals: chicken estrogen receptors, for example, have affinity for the pesticide chlorde-
cone 100-fold higher than in the rat [3]. Endocrine disruption has already been documented in popula-
tions of nonmammalian vertebrates at environmental concentrations (i.e., refs [48,49]).
IMPLICATIONS FOR ENDOCRINE DISRUPTION
The evolutionary insights discussed in this paper have two major implications for endocrine disruption
assessment and policy, which currently rely largely on testing in model vertebrates to identify individ-
ual EDs that interact with a few NRs. For example, U.S. EPA’s Endocrine Disruptor Screening Program
is using assays on mammals, amphibians, and teleosts to identify disruptors of the estrogen, androgen,
and thyroid disruptors only [20]. 
The first insight is this: NRs have diversified so extensively in the many metazoan lineages that
scientific and policy efforts focused on a few receptors in a few vertebrate classes cannot be expected
to protect all species from all kinds of endocrine disruption. Since their origin, NRs have been diversi-
fying independently in all the major metazoan lineages over many billions of years of parallel evolu-
tionary time. Each receptor in each taxonomic lineage has the potential, often realized, to be function-
ally unique. It is therefore not possible to predict with confidence the existence, ligands, and functions
of NRs in taxa that have not been specifically and empirically evaluated. The more distantly related a
species is from mammalian models, the longer the evolutionary time over which its receptors have been
diversifying, and the less reliable extrapolations from mammals will be. Programs to identify EDs using
vertebrate models are therefore likely to falsely judge as non-EDs chemicals that are in fact ligands for
nonmammalian NRs. The broad diversity of ligands for which NRs have evolved affinity implies that a
J. W.THORNTON
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the potential to disrupt NR-mediated signaling.
Endocrine disruptor screening and testing programs should be expanded to evaluate a broader
array of nonmammalian taxa. Such programs might be expanded to include, for example, testing of sev-
eral classes each of arthropods, mollusks, annelids, cnidarians, echinoderms, and nonmammalian ver-
tebrates. Such a program would be very demanding of time and resources, and it would leave numer-
ous  phyla  and  taxonomic  classes  empirically  unevaluated.  Still,  it  is  the  only  way  to  gain  even
preliminary insight into the effects of synthetic chemicals on the endocrine systems of nonmammalian
taxa and avoid false negative judgments of chemical safety. 
The second insight relates to the impact of limited knowledge on ED science and policy. Current
understanding of NRs and their functions throughout the Metazoa barely scratches the surface of their
actual diversity. The full nuclear receptor complement is known for only two model invertebrates, and
these are unfortunately relatively closely related to each other. In poorly studied taxa like echinoderms,
mollusks, and annelids, our understanding of the NRs present and their functions ranges from very lit-
tle to absolutely nothing. Even in such well-studied model organisms as humans, mice, and flies, we re-
main uncertain of the ligands and physiological functions of many receptors. To some extent, knowl-
edge gaps can be repaired with more research. But the gaps are so great that we cannot even design an
adequate program to identify EDs and their impacts in most nonmammalian taxa. The physiological/de-
velopmental roles of most NRs are unknown in the majority of invertebrate taxa; these roles have di-
versified so thoroughly that the endpoints used as indicators of endocrine disruption based on their func-
tion in mammals are seldom appropriate in invertebrates. At present, then, we lack the background
knowledge to develop in vivo assays for endocrine disruption in most nonmammalian taxa, and extrap-
olation across phyla, classes, and receptors is often unreliable. 
Efforts to identify as many endocrine disruptors as possible through broader testing are undoubt-
edly valuable for scientific and regulatory purposes. But we cannot be confident that any feasible test-
ing program will be able to identify all—or even the majority—of EDs in animals. EDs that interact
with receptors in bacteria, fungi and plants are even further beyond the ken of such a program. The
likely outcome of current testing programs’ focus on vertebrates and a small number of nuclear recep-
tors is that a nontrivial number of EDs will be judged safe, though they may be capable of causing sig-
nificant ecological damage. This situation will not be remedied soon, and exposure to endocrine-dis-
rupting chemicals will continue as long as policies require each and every endocrine disruptor to be
individually and positively identified before action can be taken to reduce its production or use.
To cope with our lack of knowledge on metazoan endocrinology and endocrine disruption, envi-
ronmental policies can be based on the precautionary principle: action should be taken to prevent plau-
sible environmental hazards even in the absence of specific and definitive evidence of damage [50].
Rather than requiring evidence of endocrine disruption for each and every chemical, as current policies
do, a precautionary framework would prioritize classes of substances that are particularly likely to con-
tain EDs, based on their structure, size, hydrophobicity, and persistence. Policies would then focus on
avoiding the production and use of members of these classes by developing and implementing safer ma-
terials and processes [51], based on the principles of sustainability and green chemistry [52]. 
CONCLUSIONS 
Over the course of billions of years, receptors and the organisms in which they function have been
evolving endocrine systems that are astonishing in their complexity, diversity, and biological impor-
tance. Protecting the life forms and ecosystems that have emerged from this evolutionary process will
require that our policies take account of these characteristics. Expanding testing programs is useful, but
true prevention of endocrine disruption will require a new approach to chemicals management that be-
gins with a recognition of the limits as well as the strengths of current scientific tools and knowledge
in the face of nature’s diversity and complexity.
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